Although participation in a mesothelioma trial -Mesothelioma Clinical Trials
may sound like a great way to connect with promising new treatments, not every mesothelioma patient is a candidate. Because clinical trials are established with specific goals, most have specific guidelines as to the type of patients they are willing to treat. For example, some trials only accept patients who have received tiny or no benefit from other therapies, while others only take individuals who have not yet started any treatment.
Clinical trials are human studies -Mesothelioma Clinical Trials
of new drugs & treatments to decide whether or not they ought to be approved by the FDA. Clinical trials for mesothelioma are ongoing, primarily at major medical centers around the country. Because mesothelioma is an aggressive cancer, plenty of trials are focused on ways to detect it earlier & treat it more effectively with various combinations of therapies.
Mesothelioma trials like all clinical trials are conducted in phases. Phase I trials usually recruit a smaller number of participants & focus on determining safety & dosing. In Phase II trials, researchers try to decide if a drug or treatment actually has efficacy. If the treatment shows promise & is safe, its effectiveness is compared to that of existing treatments in a Phase III trial.
There's both advantages & disadvantages to being involved in a mesothelioma clinical trial. Even if a patient meets the criteria for a trial & is accepted to participate, there is no guarantee that they will receive the new treatment, since some trials require a group of participants to receive the elderly treatments for a basis of comparison. In addition, the time spent
experimenting
in a clinical trial could be used in lieu to be receiving a proven existing treatment.
On the positive side, clinical trial participants often receive excellent health care since they must be monitored closely as part of the study. There is the chance that a new treatment may offer actual benefits over existing treatments. & there is the intangible benefit of at least increasing a knowledge base that may lead to better treatments in the future.
The National Institute of Health provides a current list of ongoing clinical trials for mesothelioma. A number of the studies going on now include: Mesothelioma Clinical Trials
Although chemotherapy, radiation & surgical procedure stay the primary treatments again mesothelioma, lots of of the most recent trials are focused on therapies that can target the tumor cells more effectively, without harming surrounding tissues. A number of these newer drugs aim to slow tumor growth by robbing cells of vital enzymes, inhibiting their ability to replicate, or harnessing the body�s own immune technique to assault them.
Studies of several new oral medications against advanced pleural mesothelioma where traditional chemotherapy has failed
A study of an under-the-tongue spray medication for mesothelioma pain
A study on the effectiveness of video-assisted surgical procedure for mesothelioma tumors
Several studies on the addition of a third chemotherapy drug to the standard two-drug mixture
A study on the effectiveness of administering a heated chemotherapy drug in the operating room, immediately following mesothelioma surgical procedure
A study on a new drug, AZD2171, that may cease the growth of tumors in patients who are not candidates for surgical procedure
Gene therapy for pleural mesothelioma-Mesothelioma Clinical Trials
A study on the effectiveness of combining chemotherapy with Intensity Modulated Radiation Therapy in mesothelioma
may sound like a great way to connect with promising new treatments, not every mesothelioma patient is a candidate. Because clinical trials are established with specific goals, most have specific guidelines as to the type of patients they are willing to treat. For example, some trials only accept patients who have received tiny or no benefit from other therapies, while others only take individuals who have not yet started any treatment.
Clinical trials are human studies -Mesothelioma Clinical Trials
of new drugs & treatments to decide whether or not they ought to be approved by the FDA. Clinical trials for mesothelioma are ongoing, primarily at major medical centers around the country. Because mesothelioma is an aggressive cancer, plenty of trials are focused on ways to detect it earlier & treat it more effectively with various combinations of therapies.
Mesothelioma trials like all clinical trials are conducted in phases. Phase I trials usually recruit a smaller number of participants & focus on determining safety & dosing. In Phase II trials, researchers try to decide if a drug or treatment actually has efficacy. If the treatment shows promise & is safe, its effectiveness is compared to that of existing treatments in a Phase III trial.
There's both advantages & disadvantages to being involved in a mesothelioma clinical trial. Even if a patient meets the criteria for a trial & is accepted to participate, there is no guarantee that they will receive the new treatment, since some trials require a group of participants to receive the elderly treatments for a basis of comparison. In addition, the time spent
experimenting
in a clinical trial could be used in lieu to be receiving a proven existing treatment.
On the positive side, clinical trial participants often receive excellent health care since they must be monitored closely as part of the study. There is the chance that a new treatment may offer actual benefits over existing treatments. & there is the intangible benefit of at least increasing a knowledge base that may lead to better treatments in the future.
The National Institute of Health provides a current list of ongoing clinical trials for mesothelioma. A number of the studies going on now include: Mesothelioma Clinical Trials
Although chemotherapy, radiation & surgical procedure stay the primary treatments again mesothelioma, lots of of the most recent trials are focused on therapies that can target the tumor cells more effectively, without harming surrounding tissues. A number of these newer drugs aim to slow tumor growth by robbing cells of vital enzymes, inhibiting their ability to replicate, or harnessing the body�s own immune technique to assault them.
Studies of several new oral medications against advanced pleural mesothelioma where traditional chemotherapy has failed
A study of an under-the-tongue spray medication for mesothelioma pain
A study on the effectiveness of video-assisted surgical procedure for mesothelioma tumors
Several studies on the addition of a third chemotherapy drug to the standard two-drug mixture
A study on the effectiveness of administering a heated chemotherapy drug in the operating room, immediately following mesothelioma surgical procedure
A study on a new drug, AZD2171, that may cease the growth of tumors in patients who are not candidates for surgical procedure
Gene therapy for pleural mesothelioma-Mesothelioma Clinical Trials
A study on the effectiveness of combining chemotherapy with Intensity Modulated Radiation Therapy in mesothelioma
No comments:
Post a Comment